Author

Josh Aleksanyan

Observed name: Joshua Aleksanyan

Institutions: NYU Langone Health, Friends Research Institute, New York University, Columbia University

Observed institutions: NYU Langone Health, Friends Research Institute, New York University, Columbia University

ORCID: 0000-0001-6699-2143

Observed ORCID: 0000-0001-6699-2143

OpenAlex ID: A5030851743

Reproductive rights at the U.S. state level and medication access for pregnant women with opioid use

2024 · Josh Aleksanyan, Ichiro Kawachi, et al. · Social Science & Medicine · 8

Lost in transition: A protocol for a retrospective, longitudinal cohort study for addressing challenges in opioid treatment for transition-age adults

2024 · Josh Aleksanyan, Sugy Choi, et al. · PLoS ONE · 4

Perspectives of treatment providers overseeing substance use disorder treatment among transition-age adults, aged 18–25 years

2025 · Josh Aleksanyan, Zobaida Maria, et al. · Journal of Substance Use and Addiction Treatment · 3

Beyond Age: Transition Age Adults Have Distinct Identities, Substance Use Patterns Compared With Other Adults in Substance Use Disorder Treatment

2026 · Vanessa Drury, Josh Aleksanyan, et al. · Journal of Addiction Medicine · 1

Governing beyond the closet: Remaking stigma, identity, and sexual behavior in a post-disciplinary rehab

2020 · Josh Aleksanyan · Ethnography · 1

Utilizing administrative data for provider recruitment in qualitative research: insights from a pharmacy claims-based case study

2026 · Diego Renteria, Adetayo Fawole, et al. · BMC Medical Research Methodology

Methamphetamine Co-Use Among Pregnant Individuals Using Opioids in the United States, 2011–2023

2026 · Kwanbo Shim, Elizabeth Knopf, et al. · Obstetrics and Gynecology

Too young for medication? prescriber perspectives on how age shapes medication for opioid use disorder prescribing in transition-age adults

2026 · Diego Renteria, Adetayo Fawole, et al. · Harm Reduction Journal

Works count: 8

Citation count: 17

H-index: 3

I10-index: